- Randomization method: 1:1 ratio and stratified by smoking status. The order of use of the inhaler was randomly assigned.
- Allocation concealment: Yes
- Blinding: Yes
    - -Participants: Yes
    - -Investigators: Yes
    - -Outcome assessors: Yes
- Intention-to-treat: Yes
- Follow-up period: 12 week
- Loss to follow-up: 60 (7.5%)/61 (7.6%) in each group

| ITT anlaysis | Indacaterol 150 μg | Tiotropium 18 μg |
|---|---|---|
| Number | 794 | 799 |
| Age | 63.6±8.6 | 63.4±8.29 |
| Sex (M) | 70% | 67% |
| Ethnicity | 95% Caucasian | 95% Caucasian |
| Inclusion | - Aged 40 years or older<br>- A smoking history of ≥10 pack yrs<br>- A diagnosis of moderate-to-severe COPD (30≦FEV₁＜80, FEV₁/FVC＜0.7) | |
| Exclusion | - A history of asthma<br>- Recent COPD exacerbation or respiratory infection | |
| Intervention | Indacaterol 150 μg once daily | Tiotropium, 18 μg once daily |
| Result | | |
| Number | 794 | 799 |
| Change from baseline of trough FEV₁ | 0.13 L (11.1%) | 0.12 L (10.6%) |
| Change from baseline of TDI | 2.01±0.178 | 1.43±0.178 |
| OR of likelihood of achieving ≥1 | 1.49 (95%CI 1.19~1.85) | 1.43±0.178 |
| Health status (SGRQ-C) | | |
| Total score | -5.1±12.06 | -3.0±11.64 |
| OR of likelihood of achieving ≥4 | 1.43 (95%CI 1.15~1.78) | 1.43 (95%CI 1.15~1.78) |
| Mean change in rescue medication | -1.4 | -0.85 |
| COPD Exacerbations | 85 (10.7%) | 66 (8.3%) |
| Total withdrawal | 60 (7.5%) | 61 (7.6%) |
| Withdrawal due to treatment failure | 1 (0.1%) | 3 (0.4%) |
| Withdrawal due to adverse effects | 31 (3.9%) | 27 (3.4%) |
| Adverse effects | 315 (39.7%) | 297 (37.2%) |
| Serious adverse effects | 2.8% | 3.8% |
| All cause mortality | 0 | 2 |
| % patients with glucose >9.9 mmol/L | 3.3% | 2.6% |
| QTc >60 ms | 2.9% | 3.1% |
| Non-acute cough | 37 (4.7%) | 27 (3.4%) |

### 근거표 7-2: ICS/LABA vs tiotropium

| 연구수 | 연구설계 | 비뚤림 위험 | 비일관성 | 비직접성 | 비정밀 | 출판 비뚤림 | 근거수준 |
|---|---|---|---|---|---|---|---|
| 1 | 무작위대조군 | 없음 | 있음 | 없음 | 있음 | 없음 | 낮음 |

- Author, year publication: Welsh EJ, Cochrane Database of Systemic Review 2011
- Title: Combination inhaled steroid and long-acting beta2-agnonist versus tiotropium for stable chronic obstructive pulmonary disease

<PAGE>113